Cullinan Oncology Completes $98.5 Million Series B Financing
Go back to Cullinan Oncology Completes $98.5 Million Series B Financing| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 65.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.47 | 52 Week High | $77.12 | |||
| Open | $65.47 | 52 Week Low | $49.03 | |||
| Day High | $65.47 | P/E | 42.51 | |||
| Day Low | $65.47 | EPS | $1.54 | |||
| Volume | 2,185 | |||||
| MACROGENICS (NASDAQ: MGNX) | Delayed: 4.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.07 | 52 Week High | $36.11 | |||
| Open | $4.07 | 52 Week Low | $14.84 | |||
| Day High | $4.07 | P/E | 10.44 | |||
| Day Low | $4.07 | EPS | $0.39 | |||
| Volume | 344 | |||||
